Man Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.7M Buy
52,089
+19,144
+58% +$9.64M 0.04% 413
2025
Q4
$15.4M Buy
32,945
+15,465
+88% +$7.18M 0.03% 616
2025
Q3
$7.45M Sell
17,480
-7,726
-31% -$2.99M 0.01% 916
2025
Q2
$9.66M Sell
25,206
-64,878
-72% -$23.4M 0.02% 788
2025
Q1
$31.1M Buy
90,084
+5,928
+7% +$1.91M 0.08% 293
2024
Q4
$25.3M Buy
84,156
+8,972
+12% +$3.14M 0.07% 348
2024
Q3
$30.6M Sell
75,184
-64,026
-46% -$23.4M 0.08% 309
2024
Q2
$44.7M Buy
139,210
+87,193
+168% +$28.3M 0.11% 204
2024
Q1
$17.3M Sell
52,017
-47,975
-48% -$14.7M 0.04% 475
2023
Q4
$27.1M Buy
+99,992
New +$24.7M 0.08% 304
2023
Q3
Sell
-520,216
Closed -$142M 19
2023
Q2
$158M Buy
+520,216
New +$145M 0.49% 32
2023
Q1
Sell
-26,084
Closed -$6.63M 441
2022
Q4
$6.26M Buy
26,084
+6,208
+31% +$1.39M 0.02% 752
2022
Q3
$3.65M Buy
+19,876
New +$3.96M 0.02% 852
2022
Q2
Sell
-24,242
Closed -$5.21M 1469
2022
Q1
$6.08M Sell
24,242
-84,237
-78% -$21.2M 0.02% 809
2021
Q4
$27.9M Sell
108,479
-72,548
-40% -$17.8M 0.09% 262
2021
Q3
$43.9M Sell
181,027
-69,820
-28% -$17.1M 0.15% 142
2021
Q2
$51.9M Buy
250,847
+225,600
+894% +$46M 0.18% 127
2021
Q1
$4.75M Sell
25,247
-76,511
-75% -$13.5M 0.02% 711
2020
Q4
$16.7M Sell
101,758
-196,792
-66% -$28.8M 0.07% 265
2020
Q3
$37.2M Buy
298,550
+216,525
+264% +$26.8M 0.15% 135
2020
Q2
$7.96M Sell
82,025
-578,340
-88% -$60.1M 0.04% 452
2020
Q1
$59.3M Sell
660,365
-346,660
-34% -$44.9M 0.38% 55
2019
Q4
$149M Buy
1,007,025
+161,639
+19% +$21.7M 0.49% 29
2019
Q3
$102M Sell
845,386
-95,853
-10% -$12.4M 0.38% 48
2019
Q2
$127M Sell
941,239
-67,181
-7% -$8.49M 0.46% 27
2019
Q1
$131M Sell
1,008,420
-66,371
-6% -$8.91M 0.5% 27
2018
Q4
$134M Buy
1,074,791
+902,806
+525% +$121M 0.6% 31
2018
Q3
$23.9M Sell
171,985
-60,879
-26% -$7.58M 0.09% 258
2018
Q2
$23.9M Sell
232,864
-477,760
-67% -$48.3M 0.1% 215
2018
Q1
$68.9M Buy
+710,624
New +$68.9M 0.32% 55

Other funds holding HCA

Man Group's HCA Position: Q1 2026 in Review

Man Group increased its HCA Healthcare (HCA) stake by 58% in Q1 2026, buying an estimated $9.64M and bringing the position to 52,089 shares worth $24.7M. The position accounts for 0.04% of the portfolio, ranked #413.

Man Group first reported a position in HCA in Q1 2018 and has held it in 30 quarters since. The position peaked at $158M in Q2 2023. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Man Group held 52,089 shares of HCA Healthcare worth $24.7M as of Q1 2026.
  • Man Group bought 19,144 HCA Healthcare shares in Q1 2026, an estimated $9.64M.
  • HCA Healthcare made up 0.04% of Man Group's portfolio in Q1 2026, its #413 holding.
  • Man Group first reported a position in HCA Healthcare in Q1 2018 and has held it in 30 quarters since.
  • Man Group's HCA Healthcare position peaked at $158M in Q2 2023.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.